Puente BA, Roffe GF, Aceves CJL, Gómez AE, FCortés MF

Language: Spanish
References: 20
Page: 29-34
PDF size: 71.22 Kb.

ABSTRACT

The objective of the study was to evaluate the usefulness of SPECT myocardial perfusion imaging in the detection of silent ischemia. Methods: Myocardial perfusion SPECT was performed in 184 asymptomatic patients with diagnosis of stable coronary disease. The protocol consisted of Tc-99m tetrofosmin rest/stress in one day. Coronary angiography was performed in patients with moderate to severe ischemia. The agreement among myocardial perfusion defects, ST depression, and coronary lesions was established. Results: 80% of the patients were men and 20% were women, aged 60.5 ± 10 years. The predominant risk factors were hypertension (57%), tabaquism (57%) and Diabetes Mellitus (43%). Clinical diagnoses were myocardial infarction in 77% and stable angina in 23%. The stress protocol was performed with dipyridamole in 40%, dipyridamole plus exercise in 40%, and only exercise in 20%. During the stress test all patients were asymptomatic and no evidence of ST segment changes was found in 74%. Myocardial SPECT showed necrosis in 85% of the patients, localized in the anterior descending territory (30%) and ischemia (15%) in the circumflex territory. Coronary artery disease affected the anterior descending (35%), circumflex (27%) and right coronary artery (23%). The SPECT myocardial perfusion imaging sensitivity for the detection of silent ischemia was 97%, with specificity of 97%, and predictive positive and negative value of 90% and 2%. Conclusions: The absence of chest pain and ST depression during the stress protocol were not good markers for the diagnosis of silent ischemia. Asymptomatic patients with ischemia detected in the myocardial perfusion SPECT have 3.8 more risks to have significant coronary obstructions (p ≤ 0.0001).

REFERENCES

1. Cohon PF, Fox KM, with the assitance of Caroline Daly: Silent myocardial ischemia. Circulation 2003; 108: 1263-1277.

2. Topol EJ: Texbook of Cardiovascular Medicine. Second Edition. Lippincott Williams-Wilkins 2002: 1425-32.

3. Conti CR: Silent Cardiac ischemia. AHA Prevention September 2002; 17(15): 537-42.

4. Francis Q, Thomas K, Sandeep N, Clifford K: Silent Myocardial Ischemia: Concepts and Controversies. Am J Med 2004; 116: 112-118.

5. Boon D, van Goudover J, Piek J, van Montfrans, Gert A: ST Segment Depression Criteria and the Prevalence of Silent Cardiac Ischemia in Hypertensives. AHA Inc. Scientific Contributions. March 2003; 41(3): 476-81.

6. Freeman MR, de Yang L, Langer A: Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease. Am J Cardiol 1994; 74: 137-43.

7. Beleslin BD, Ostojic M, Stepanovic J, Thomas K, Sandeep N, Clifford K: Stress echocardiography in the detection of myocardial ischemia. Circulation 1994; 90: 1168-1176.

8. Langer A, Freeman MR, Josse RG: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991; 67: 1073-1078.

9. Stern S: Angina Pectoris Without Chest Pain: Clinical Implications of Silent Ischemia. AHA Clinician Update 2002; 106(15): 1906-08.

10. Blumenthal R, Becker D, Danie M, Moy T, Coresh J, Wilder L, Becker L: Exercise Thallium Tomography Predicts Future Clinically Manifest Coronary Heart Disease in a High-Risk Asymptomatic Population. Circulation 1996; 93: 915-923.

11. Schuartz R, Jackson W, William G, Celio P, Richardson L, Hickman J: Accuracy of Exercise Thallium-201 Myocardial Scintigraphy in Asymptomatic Young Men. Circulation 1993; 87: 165-172.

12. Deedwania P, Carbajal E: Silent myocardial ischemia. A Clinical perspective. Arch Intern Med 1991; 151: 2373-2382.

13. Almeda F, Thomas K, Sndeep J: Silent Myocardial Ischemia: Concepts and Controversies. Am J Med 2004; 116: 112-118.

14. Miranda C, Lechman K, Lachterman B, Jackson W, Danie M, Richardson L: Comparison of silent and symptomatic ischemia during exercise testing in men. Ann Intern Med 1991; 114: 649-656.

15. Deedwania P: Asymptomatic ischemia during predischarge: Holter monitoring predicts poor prognosis in the post-infarction period. Am J Cardiol 1993; 71: 859-861.

16. Weiner D, Ryan T, McCabe J: Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 1987; 59: 725-729.

17. Bonow R, Bacharach S, Green M, Becker D, Danie M, Moy T: Prognostic implications symptomatic versus asymptomatic patients with angiographically document coronary artery disease. Am J Cardiol 1987; 60: 778-783.

18. Brown K: Management of unstable angina: The role of noninvasive risk stratification. J Nucl Cardiol 1997; 4: S164-168.

19. Marmur JD, Freeman MR, Langer D: Prognosis in medically stabilized unstable angina: Early Holter ST segment monitoring compared with predischarge exercise thallium tomography. Ann Int Med 1990; 113: 575.

20. Stratman H, Younis L, Wittry M: Exercise tc-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995; 76: 236-40.